Brighthouse Financial
BHF · Life & Health Insurance
$45.41
2.0%CNO Financial Group
CNO · Life & Health Insurance
$53.66
3.3%The short version
- Brighthouse Financial is the larger business, with $6.8B of revenue in fiscal 2025 against $4.5B for CNO Financial Group, about 1.5 times as much.
- Brighthouse Financial grew revenue faster (43.2%, against 0.9%).
- Investors pay more for each dollar of CNO Financial Group’s earnings: a P/E of 18.4x against 3.6x for Brighthouse Financial.
| Latest fiscal year | BHF · FY25 | CNO · FY25 |
|---|---|---|
| Size | ||
| Market cap | $2.6B | $5.1B |
| Revenue | $6.8B | $4.5B |
| Free cash flow | — | — |
| Net income | $433M | $229M |
| Growth | ||
| Revenue growth | 43.2% | 0.9% |
| 5-year growth | −4.5% | 3.3% |
| Share count change | −5.9% | −7.7% |
| Profitability | ||
| Gross margin | — | — |
| Operating margin | — | 12.3% |
| Net margin | 6.4% | 5.1% |
| FCF margin | — | — |
| Return on capital | — | — |
| Return on equity | — | 8.9% |
| Balance sheet | ||
| Net debt | −$3.4B | — |
| Net debt / EBITDA | — | — |
| Dividends and buybacks | $102M | $398M |
| Valuation & quality | ||
| P/E | 3.6x | 18.4x |
| Piotroski F-score | — | — |
FY16
BHF $3.0B
CNO $4.0B
FY17
BHF $6.8B
CNO $4.3B
FY18
BHF $9.0B
CNO $4.3B
FY19
BHF $6.6B
CNO $4.0B
FY20
BHF $8.5B
CNO $3.8B
FY21
BHF $5.0B
CNO $4.1B
FY22
BHF $6.9B
CNO $3.6B
FY23
BHF $4.1B
CNO $4.1B
FY24
BHF $4.7B
CNO $4.4B
FY25
BHF $6.8B
CNO $4.5B
BHF
CNO
FY16
BHF —
CNO —
FY17
BHF —
CNO 10.6%
FY18
BHF —
CNO 8.8%
FY19
BHF —
CNO 9.2%
FY20
BHF —
CNO 12.1%
FY21
BHF —
CNO 12.5%
FY22
BHF —
CNO 13.1%
FY23
BHF —
CNO 11.1%
FY24
BHF —
CNO 12.4%
FY25
BHF —
CNO 12.3%
BHF
CNO
FY16
BHF —
CNO —
FY17
BHF —
CNO —
FY18
BHF —
CNO —
FY19
BHF —
CNO —
FY20
BHF —
CNO —
FY21
BHF —
CNO —
FY22
BHF —
CNO —
FY23
BHF —
CNO —
FY24
BHF —
CNO —
FY25
BHF —
CNO —
BHF
CNO
FY16
BHF —
CNO 10.4%
FY17
BHF —
CNO 4.7%
FY18
BHF —
CNO 7.0%
FY19
BHF —
CNO —
FY20
BHF —
CNO —
FY21
BHF —
CNO —
FY22
BHF —
CNO —
FY23
BHF —
CNO —
FY24
BHF —
CNO —
FY25
BHF —
CNO —
BHF
CNO
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.